Pharma Urged to Register Early Trials

Mitchell, Pete
July 2006
Pharma DD: Tracking Discovery & Development;Jul/Aug2006, Vol. 1 Issue 1, p20
Academic Journal
The article focuses on the proposal of the World Health Organization (WHO) concerning the publication of plans for all clinical trials by pharmaceutical companies on the Internet that include early-stage proof-of-concept studies. WHO requires all medical studies that test treatments on human beings, including the earliest studies, whether they involve patients or healthy volunteers to be registered by research institutions and companies. Both academia and industry criticized the WHO proposal.


Related Articles

  • Credible Lit. Baiter, Wendy; Scott, Marsha // Pharmaceutical Executive;Aug2006, Vol. 26 Issue 8, p138 

    The article focuses on several developments in report publications in the pharmaceutical industry in the U.S. Review article development is moving together with the most forward-thinking companies developing internal guidelines that leave content development to the author. Another development is...

  • Raising the standards of clinical trials and research.  // Bulletin of the World Health Organization;Sep2007, Vol. 85 Issue 9, p658 

    An interview with Sir Iain Chalmers, library editor of the James Lind Library is presented. When asked about the importance of clinical trials and how does the James Lind Library fit in, he relates that clinical trial assess whether claims about the effects of treatments are dangerous or...

  • WHO to unveil global clinical trials register. Dyer, Owen // Bulletin of the World Health Organization;Sep2004, Vol. 82 Issue 9, p714 

    Reports that the World Health Organization will unveil the first global clinical trials register in November 2004. Criticisms on drug companies that suppressed vital data; Potential of the register to establish international procedures; Plans of the WHO to use an existing numbering system.

  • Result Publication of Chinese Trials in World Health Organization Primary Registries. Liu Xuemei; Li Youping; Yin Senlin; Song Shangqi // PLoS ONE;2010, Vol. 5 Issue 9, p1 

    Background: Result publication is the key step to improve the transparency of clinical trials. Objective: To investigate the result publication rate of Chinese trials registered in World Health Organization (WHO) primary registries. Method: We searched 11 WHO primary registries for Chinese...

  • Poor Reporting of Scientific Leadership Information in Clinical Trial Registers. Sekeres, Melanie; Gold, Jennifer L.; An-Wen Chan; Lexchin, Joel; Moher, David; Van Laethem, Marleen L. P.; Maskalyk, James; Ferris, Lorraine; Taback, Nathan; Rochon, Paula A. // PLoS ONE;2008, Vol. 3 Issue 2, p1 

    Background: In September 2004, the International Committee of Medical Journal Editors (ICMJE) issued a Statement requiring that all clinical trials be registered at inception in a public register in order to be considered for publication. The World Health Organization (WHO) and ICMJE have...

  • Clinical Trials Research in Pediatrics: Strategies for Effective Collaboration Between Investigator Sites and the Pharmaceutical Industry. Bush, Andrew // Pediatric Drugs;2006, Vol. 8 Issue 5, p271 

    There is a paucity of clinical trials work in children, which leads to the frequent use of off-label and unlicensed medications in this very vulnerable group. Clinical trials work in children may be more difficult than in adults, and there are certainly ethical constraints. However, the...

  • Clinical Trials in Children. Parish, Lawrence Charles // Pediatrics for Parents;2004, Vol. 21 Issue 8, p5 

    The article focuses on clinical trials in children. Clinical trials did not always exist. When aspirin was introduced in the late nineteenth century, patients fried it but not in an organized fashion and only by chance, or perhaps it was through serendipity, that this wonder drug came to relieve...

  • Major Medical Journals Will Require That Randomized Trials Be Registered.  // AIDS Treatment News;6/24/2005, Issue 413, p6 

    Comments on the refusal of some drug companies to comply with the registration of randomized trials to avoid disclosing their activities to their competitor. Mandate of medical journals that they will consider a trial for publication only if it has been registered before enrollment of the first...

  • CULTURE CLUBS. Kibby, Matthew // Pharmaceutical Executive;Apr2006, Vol. 26 Issue 4, p106 

    The article reports on the role of ethics committees in a worldwide clinical trial. Their review systems are crucial to the development of global regulatory climate concerning patient-recruitment advertising. They are also consigned with ensuring protection, safety and welfare of clinical trial...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics